Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-2.18%||67.34||1.0%||$534.08m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.34%||605.25||2.7%||$434.03m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.23%||226.58||1.9%||$358.72m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.71%||2.63||0.7%||$183.85m|
|EXAS||EXACT Sciences Corp.||-0.42%||68.89||17.9%||$173.71m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.29%||89.63||13.7%||$135.69m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.37%||83.70||4.2%||$108.53m|
|CRSP||CRISPR Therapeutics AG||-1.12%||61.84||0.6%||$107.20m|
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-FranÃ§ois Mouney, Florence SÃ©journÃ©, and Bart Staels in September 1999 and is headquartered in Loos, France.